<DOC>
	<DOCNO>NCT02341638</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics ( PK ) pharmacodynamics ( PD ) single multiple oral dos BMS-986141 healthy subject .</brief_summary>
	<brief_title>Single Multiple Ascending Dose Study Evaluate Safety , Tolerability , Pharmacokinetics Pharmacodynamics BMS-986141 Healthy Subjects</brief_title>
	<detailed_description>Maximum Age : Part A SAD 65 year Part B MAD 75 year Part C MAD Japanese 75 year</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com 1 . Healthy male female subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination 2 . Body Mass Index ( BMI ) 18 32 kg/m2 , inclusive . BMI=Weight ( kg ) / [ height ( ) ] 2 3 . Women childbearing potential ( i.e. , postmenopausal surgically sterile ) men , age 18 75 , inclusive 1 . Concurrent use within 2 week study drug administration , market investigational , drug specify protocol 2 . Other protocoldefined exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>